Recent evidence points to an imbalance between NET formation and NET clearance in SLE [185, 190–192] and decreased NET degradation has been associated with complement activation [193] and correlated with a subset of SLE patients with renal disease and attended by DNase1 inhibitors and anti-NET antibodies [185]. Here, DNASE1 is linked to systemic lupus erythematosus.